8-K 1 ea133505-8k_mountaincrest2.htm CURRENT REPORT





Washington, D.C. 20549


Form 8-K


Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


January 12, 2021

Date of Report (Date of earliest event reported)


Mountain Crest Acquisition Corp. II

(Exact Name of Registrant as Specified in its Charter)


Delaware   001-39864   85-3472546
(State or other jurisdiction
of incorporation) 
  (Commission File Number)   (I.R.S. Employer
Identification No.)


311 West 43rd Street, 12th Floor

New York, NY

(Address of Principal Executive Offices)   (Zip Code)


Registrant’s telephone number, including area code: (646) 493-6558



(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act


Soliciting material pursuant to Rule 14a-12 under the Exchange Act


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act


Securities registered pursuant to Section 12(b) of the Act:


Title of each class   Trading Symbol(s)   Name of each exchange on
which registered
Common Stock   MCAD   The Nasdaq Stock Market LLC
Rights   MCADR   The Nasdaq Stock Market LLC
Units   MCADU   The Nasdaq Stock Market LLC


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).


Emerging growth company ☒


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐







Item 3.02. Unregistered Sales of Equity Securities.


The information included in Item 8.01 is incorporated into this Item by reference.


Item 8.01. Other Events


As previously disclosed on a Current Report on Form 8-K dated January 13, 2021, on January 12, 2021 Mountain Crest Acquisition Corp. II (the “Company”) consummated the IPO of 5,000,000 units (the “Units”). Each Unit consists of one share of common stock, $0.0001 par value (“Common Stock”), and one right (“Right”) to receive one-tenth (1/10) of a share of common stock upon the consummation of an initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $50,000,000. The Company granted the underwriters a 45-day option to purchase up to 750,000 additional Units to cover over-allotments (the “Over-Allotment Option Units”).


On January 14, 2021, the underwriters exercised the over-allotment option and the Company issued the Over-Allotment Option Units to the underwriters. The total aggregate issuance by the Company of the Over-Allotment Option Units at a price of $10.00 per unit resulted in total gross proceeds of $7,500,000. On January 14, 2021, simultaneously with the sale of the Over-Allotment Option Units, the Company consummated the private sale of an additional 15,000 Private Units, generating gross proceeds of $150,000. The Private Units were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.


A total of $57,500,000 of the net proceeds from the sale of Units in the initial public offering (including the Over-Allotment Option Units) and the Private Placements on January 12, 2021 and January 14, 2021, were placed in a trust account established for the benefit of the Company’s public shareholders.


An audited balance sheet as of January 12, 2021 reflecting receipt of the proceeds upon consummation of the IPO and the private placement is included with this report as Exhibit 99.1, and a pro-forma balance sheet reflecting the exercise of the over-allotment option is included as Exhibit 99.2.


Item 9.01. Financial Statements and Exhibits.


Exhibit No.

99.1   Balance Sheet dated January 12, 2021
99.2   Pro-Forma Balance Sheet dated January 14, 2021







Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: January 19, 2021




By: /s/ Suying Liu  
Name:  Suying Liu  
Title: Chief Executive Officer